tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BCAB Stock Latest News

BioAtla Reports Q3 2024 Financial Results and Clinical Advances
Company AnnouncementsBioAtla Reports Q3 2024 Financial Results and Clinical Advances
1d ago
BCAB
BioAtla reports Q3 EPS (22c), consensus (36c)
PremiumThe Fly
BioAtla reports Q3 EPS (22c), consensus (36c)
2d ago
BCAB
BioAtla, Context Therapeutics enter exclusive license agreement for BA3362
PremiumThe Fly
BioAtla, Context Therapeutics enter exclusive license agreement for BA3362
2M ago
BCAB
CNTX
BioAtla presented poster of Phase 2 trial data at ESMO meeting
PremiumThe Fly
BioAtla presented poster of Phase 2 trial data at ESMO meeting
2M ago
BCAB
BioAtla rallies after Burry’s Scion discloses new stake
PremiumThe Fly
BioAtla rallies after Burry’s Scion discloses new stake
3M ago
BCAB
BioAtla management to meet virtually with BTIG
PremiumThe FlyBioAtla management to meet virtually with BTIG
3M ago
BCAB
These 2 “Strong Buy” Penny Stocks Are Poised for a Big Rally, Say Analysts
Premium
Stock Analysis & Ideas
These 2 “Strong Buy” Penny Stocks Are Poised for a Big Rally, Say Analysts
3M ago
BCAB
CRMD
BioAtla to hold an analyst research and development day
Premium
The Fly
BioAtla to hold an analyst research and development day
4M ago
BCAB
BioAtla granted FDA FTD for ozuriftamab vedotin
PremiumThe Fly
BioAtla granted FDA FTD for ozuriftamab vedotin
4M ago
BCAB
BioAtla price target lowered to $5 from $12 at JMP Securities
PremiumThe Fly
BioAtla price target lowered to $5 from $12 at JMP Securities
6M ago
BCAB
BioAtla reports Q1 EPS (48c), consensus (79c)
PremiumThe Fly
BioAtla reports Q1 EPS (48c), consensus (79c)
6M ago
BCAB
BCAB Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
BCAB Upcoming Earnings Report: What to Expect?
6M ago
BCAB
BioAtla announces FDA clearance of IND for BA3361
PremiumThe FlyBioAtla announces FDA clearance of IND for BA3361
6M ago
BCAB
BioAtla price target lowered to $7 from $10 at H.C. Wainwright
Premium
The Fly
BioAtla price target lowered to $7 from $10 at H.C. Wainwright
8M ago
BCAB
BioAtla reports Q4 revenue $7.8M vs $5.8M last year
Premium
The Fly
BioAtla reports Q4 revenue $7.8M vs $5.8M last year
8M ago
BCAB
BioAtla reports Q4 net loss $26.9M vs. $27.6M last year
PremiumThe Fly
BioAtla reports Q4 net loss $26.9M vs. $27.6M last year
8M ago
BCAB
Is BCAB a Buy, Before Earnings?
PremiumPre-Earnings
Is BCAB a Buy, Before Earnings?
8M ago
BCAB
BioAtla Rewards Executives for Meeting Performance Goals
PremiumCompany Announcements
BioAtla Rewards Executives for Meeting Performance Goals
9M ago
8K
BCAB
BioAtla Faces Class Action Lawsuit Over Bylaw Provisions
PremiumCompany Announcements
BioAtla Faces Class Action Lawsuit Over Bylaw Provisions
9M ago
8K
BCAB
BioAtla CEO buys $107K in common stock
PremiumThe FlyBioAtla CEO buys $107K in common stock
11M ago
BCAB
BioAtla participates in a conference call with JPMorgan
Premium
The Fly
BioAtla participates in a conference call with JPMorgan
11M ago
BCAB
BioAtla participates in a conference call with JPMorgan
Premium
The Fly
BioAtla participates in a conference call with JPMorgan
11M ago
BCAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >